Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Correction to: Leukemia

https://doi.org/10.1038/s41375-020-0725-0

Original languageEnglish
Pages (from-to)2820-2820
Number of pages1
JournalLeukemia
Volume34
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Fingerprint

Dive into the research topics of 'Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS'. Together they form a unique fingerprint.

Cite this